These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 950737)

  • 21. Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
    Simpson GM; Beckles D; Isalski Z; Lee JH
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):142-52. PubMed ID: 4553448
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
    Bourgeois M; Bouey P
    Ann Med Psychol (Paris); 1976 Nov; 2(4):669-708. PubMed ID: 1020864
    [No Abstract]   [Full Text] [Related]  

  • 23. The neuroleptics. 4. Toxicity and side effects in man and in the laboratory animal.
    Degkwitz R; Heushgem C; Hollister LE; Jacob J; Julou L; Lambert PA; Marsboom R; Meier-Ruge W; Schaper WK; Tuchmann-Duplessis HC
    Mod Probl Pharmacopsychiatry; 1970; 5():71-84. PubMed ID: 5527173
    [No Abstract]   [Full Text] [Related]  

  • 24. The rabbit syndrome. A peculiar extrapyramidal reaction.
    Villeneuve A
    Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS69-. PubMed ID: 5042912
    [No Abstract]   [Full Text] [Related]  

  • 25. The extrapyramidal neuroleptic syndrome: description and measurement.
    Elie R; Gagnon MA; Lamontagne Y; Tetreault L
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):427-40. PubMed ID: 4198304
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H; Chien CP; Cole JO
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extrapyramidal symptoms following Clozapine therapy. Case report].
    Doepp S; Buddeberg C
    Nervenarzt; 1975 Oct; 46(10):589-90. PubMed ID: 811999
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention and management of tardive dyskinesia.
    Crane GE
    Am J Psychiatry; 1972 Oct; 129(4):466-7. PubMed ID: 5071149
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug-induced extrapyramidal symptoms].
    Janzik HH
    Dtsch Med Wochenschr; 1975 Mar; 100(11):555-7. PubMed ID: 1116439
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic approaches to tardive dyskinesia. A review of the literature.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Oct; 27(4):491-9. PubMed ID: 4116201
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced extrapyramidal syndromes.
    Lader MH
    J R Coll Physicians Lond; 1970 Oct; 5(1):87-98. PubMed ID: 4150143
    [No Abstract]   [Full Text] [Related]  

  • 33. Dyskinesia and neuroleptics.
    Crane GE
    Arch Gen Psychiatry; 1968 Dec; 19(6):700-3. PubMed ID: 5697636
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure side-effect sorting of drugs. I. Extrapyramidal syndrome.
    Lien EJ; Gudauskas GA
    J Pharm Sci; 1973 Apr; 62(4):645-7. PubMed ID: 4698989
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa.
    Kazamatsuri H; Cole JO
    Arch Gen Psychiatry; 1972 Dec; 27(6):824-7. PubMed ID: 4637899
    [No Abstract]   [Full Text] [Related]  

  • 36. [Secondary neurologic manifestations of psychotropic therapeutics. Neurophysiological approach].
    Rigal J; Savelli A; Juillet P
    Ann Med Interne (Paris); 1972 May; 123(5):541-7. PubMed ID: 4263578
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylphenidate in tardive dyskinesia.
    Fann WE; Davis JM; Wilson IC
    Am J Psychiatry; 1973 Aug; 130(8):922-4. PubMed ID: 4577471
    [No Abstract]   [Full Text] [Related]  

  • 39. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.
    Crane GE
    Am J Psychiatry; 1968 Feb; 124(8):Suppl:40-8. PubMed ID: 4865731
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic problems of the so-called impregnation syndrome due to neuroleptics].
    Casacchia M; Carolei A; Zamponi A; Argenta G
    Clin Ter; 1975 Dec; 75(6):645-8. PubMed ID: 1220891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.